Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people (vol 32, pg 517, 2007)

被引：0
|
作者：
Hu, Xiang-peng [1 ]
机构：
[1] Wenzhou Med Coll, Affiliated Hosp 1, Ctr Endoscop Diag & Therapy, Wenzhou, Peoples R China
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2007年 / 32卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：659 / 659
页数：1
相关论文
共 50 条
  • [1] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people
    Hu, Xiang-Peng
    Xu, Jian-Ming
    Hu, Yong-Mei
    Mei, Qiao
    Xu, Xin-Hua
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 517 - 524
  • [2] EFFECTS OF CYP2C19 HAPLOTYPE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF OMEPRAZOLE
    Bae, J. W.
    Choi, C., I
    Kim, M. J.
    Jang, C. G.
    Lee, S. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 79 - 80
  • [3] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
    Yu, KS
    Yim, DS
    Cho, JY
    Park, SS
    Park, JY
    Lee, KH
    Jang, IJ
    Yi, SY
    Bae, KS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 266 - 273
  • [4] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Tan, Bo
    Zhang, Yi-Fan
    Chen, Xiao-Yan
    Zhao, Xiao-Hua
    Li, Guo-Xin
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 145 - 151
  • [5] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Bo Tan
    Yi-Fan Zhang
    Xiao-Yan Chen
    Xiao-Hua Zhao
    Guo-Xin Li
    Da-Fang Zhong
    European Journal of Clinical Pharmacology, 2010, 66 : 145 - 151
  • [6] Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
    Boulenc, Xavier
    Djebli, Nassim
    Shi, Juan
    Perrin, Laurent
    Brian, William
    Van Horn, Robert
    Hurbin, Fabrice
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 187 - 197
  • [7] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Cho, Chang-Keun
    Byeon, Ji-Young
    Kang, Pureum
    Park, Hye-Jung
    Ko, Eunvin
    Mu, Chou Yen
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (02) : 111 - 116
  • [8] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Chang‑Keun Cho
    Ji-Young Byeon
    Pureum Kang
    Hye-Jung Park
    Eunvin Ko
    Chou Yen Mu
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 : 111 - 116
  • [9] Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19
    Yu, BN
    Chen, GL
    He, N
    Ouyang, DS
    Chen, XP
    Liu, ZQ
    Zhou, HH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) : 1255 - 1259
  • [10] Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19
    Wang, JH
    Liu, ZQ
    Wang, W
    Chen, XP
    Shu, Y
    He, N
    Zhou, HH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (01) : 42 - 47
12345